Nanotechnology in Apiculture: A Critical Narrative Review of Colony Health, Pollinator Safety, Nano-enabled Quality Control and Bee-product Valorisation

Abstract

Nanotechnology is increasingly intersecting with apiculture through engineered nanoparticles, nanoformulated crop-protection products, nano-enabled analytical sensors and nanostructured delivery systems for bee-derived materials. Yet the evidence is fragmented across apicultural science, entomotoxicology, food analysis, materials science and biomedical engineering, making it difficult to distinguish interventions that plausibly benefit managed colonies from technologies that merely use bee products as raw materials or expose pollinators to new hazards. This critical narrative review evaluates the principal application domains and their evidential maturity. The strongest direct apicultural evidence remains limited: chitosan nanoparticles have shown colony-performance benefits in a field study, while silver- and zinc-based nanomaterials have demonstrated activity against important bacterial and fungal bee pathogens, largely under laboratory conditions. In contrast, a broader toxicological literature shows that engineered metal and metal-oxide nanoparticles and nanopesticide formulations can alter survival, gut integrity, microbiota, detoxification, immunity and behaviour in bees, with outcomes depending on particle composition, size, carrier system, dose and exposure duration. Nano-enabled honey analysis is technically more mature, with nanoparticle-modified optical, colorimetric and electrochemical platforms demonstrating sensitive discrimination of adulteration, botanical origin and antimicrobial residues, although validation across commercial supply chains remains incomplete. Bee products also function as reducing, capping or cargo materials in nanomaterial synthesis and nanodelivery; these developments may increase the value of honey, propolis, royal jelly, venom and even dead bees, but should not be conflated with demonstrated improvements in colony health. The central translational challenge is therefore not whether nanotechnology can be applied to apiculture, but whether a given nano-enabled system provides a reproducible advantage over conventional practice without creating unacceptable risks to bees, hive products, consumers or surrounding ecosystems. Future research should prioritise field-scale comparative trials, lifecycle and residue studies, nano-specific characterisation in hive matrices, colony-level safety endpoints and fit-for-purpose regulatory assessment.